Daniel Grosu

Daniel S. Grosu is an accomplished professional dedicated to improving the well-being of pets and their owners.

With a versatile educational background, Daniel holds an MBA from Saïd Business School at the University of Oxford, an MD (with Distinction in Research) from Saint Louis University School of Medicine, an MA in Christian History & Theology from Wheaton College, and a BA in Psychology (Magna cum Laude) from Wheaton College.

Daniel has held key roles in various prestigious organizations, including serving as the Founder, President & CEO of PetDx, and previously as the Founder & Managing Partner at GENOPRAXIS, LLC.

His experience extends to top executive positions such as Chief Medical Officer & SVP at Sequenom, Inc., Vice President of Clinical Development & Medical Affairs at Illumina, Inc., and Chief Medical Officer at Illumina, Inc.

In addition, he has served as Group Director of Clinical Science at Ortho Clinical Diagnostics (a Johnson & Johnson company), Director of Global Clinical Development, Diagnostic Imaging, and Director of Medical Affairs, Diagnostic Imaging at Bayer HealthCare Pharmaceuticals.

Daniel's expertise also includes roles as Principal Consultant of Global Solutions at Siemens Medical Solutions USA Inc., and managerial positions in R&D Collaborations and Market Development at the same company.

Furthermore, his professional journey began as a Resident in Internal Medicine at SSM Health Saint Louis University Hospital, showcasing a well-rounded background in the medical field.